Cooperative Agreement UG3CA293878
Award Date 7/25/25
Completion Date 5/31/27
Dollars Obligated $676K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Maryland, USA
Similar Awards
- This $5,041,790 cooperative agreement award from the National Cancer Institute (NCI), under the Cancer Centers Support Grants program (CFDA 93.397), will fund research projects at the University of California, San Francisco (UCSF) to improve cancer health disparities. The key products and services to be delivered include: Three translational cancer health disparities research projects focused on meningioma, prostate cancer, and breast cancer. The projects aim to evaluate the interplay of...
- This $658,743 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Kaiser Foundation Hospitals aims to develop and validate prediction models for trajectories of function, cognition, and quality of life among adults aged 65 and older with advanced non-small cell lung cancer during up to 6 months of chemotherapy and/or immunotherapy. The 5-year project builds on an ongoing observational cohort study of 130 older adults with advanced lung...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This Cooperative Agreement award for $703,321.00, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393), will support the adaptation and implementation of an evidence-based patient navigation intervention for adolescent and young adult (AYA) cancer survivors. The project aims to improve coordination of care, including surveillance for cancer recurrence, management of long-term effects, and delivery of preventive and...
- The National Cancer Institute (NCI), through the Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $130,301 Project Grant to The Johns Hopkins University. The grant, awarded on September 5, 2025, will support research to extend the Surveillance, Epidemiology, and End Results (SEER)-Medicare database, a critical data linkage that enables studies on the delivery of high-quality cancer care. As the Core Manager of the Biostatistics Shared Resource at the Sidney Kimmel...
- The National Cancer Institute awarded a $673,096 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The grant is designed to improve cancer and mental health care delivery for adults affected by serious mental illness (SMI) across a cancer center network. The project aims to develop and evaluate the BRIDGE model of person-centered collaborative care, which...
- This Cooperative Agreement award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $686,993 to The Trustees of Columbia University in the City of New York to implement electronic health record (EHR)-based strategies and decision support for increasing hereditary breast and ovarian cancer (HBOC) genetic testing among multiethnic women. The project aims to address the significant underutilization of HBOC genetic testing, particularly among women of...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $624,000.00 to the University of Texas Health Science Center at Houston to explore a patient priorities care framework for improving breast cancer survivorship care for older women with multiple chronic conditions. The project aims to use this framework to identify patient priorities, incorporate them into treatment plans, and evaluate the feasibility and impact on treatment burden and quality...
- This $663,383 Project Grant was awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Georgetown University on August 1, 2025. The project aims to conduct proactive outreach and provide streamlined genetic testing for prostate cancer survivors. This research is crucial to customize cancer treatment and guide prevention, as germline pathogenic variants in DNA-repair genes are common and clinically significant in prostate cancer patients. Despite clear...
- The National Cancer Institute awarded a $197,747 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of North Carolina at Chapel Hill. The grant, titled "IMPROVING AFFORDABILITY IN CANCER CARE THROUGH ECONOMIC SCREENING AND SUPPORT (I-ACCESS)", aims to pilot and refine a screening assessment and referral program to proactively identify cancer-related financial hardship in patients and connect them with financial education, counseling, and resources....